Q&A: George Church on Genomics of Cognitive Enhancement
Bill of Health
JUNE 12, 2024
The practicality I’ve noticed over the years is that no matter what we aim at, there’s the very severe, shorter-term FDA trial. In 2005 the topic was consent for public release of human data. GC: It has piqued my interest for many years. In 2004 this was chip synthesis of pathogen DNA. In 2014 CRISPR gene drives.
Let's personalize your content